Correlation Between Bio Techne and Vaxcyte
Can any of the company-specific risk be diversified away by investing in both Bio Techne and Vaxcyte at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bio Techne and Vaxcyte into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bio Techne Corp and Vaxcyte, you can compare the effects of market volatilities on Bio Techne and Vaxcyte and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bio Techne with a short position of Vaxcyte. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bio Techne and Vaxcyte.
Diversification Opportunities for Bio Techne and Vaxcyte
-0.06 | Correlation Coefficient |
Good diversification
The 3 months correlation between Bio and Vaxcyte is -0.06. Overlapping area represents the amount of risk that can be diversified away by holding Bio Techne Corp and Vaxcyte in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaxcyte and Bio Techne is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bio Techne Corp are associated (or correlated) with Vaxcyte. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaxcyte has no effect on the direction of Bio Techne i.e., Bio Techne and Vaxcyte go up and down completely randomly.
Pair Corralation between Bio Techne and Vaxcyte
Given the investment horizon of 90 days Bio Techne Corp is expected to generate 0.67 times more return on investment than Vaxcyte. However, Bio Techne Corp is 1.48 times less risky than Vaxcyte. It trades about -0.01 of its potential returns per unit of risk. Vaxcyte is currently generating about -0.06 per unit of risk. If you would invest 7,523 in Bio Techne Corp on November 1, 2024 and sell it today you would lose (247.00) from holding Bio Techne Corp or give up 3.28% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Bio Techne Corp vs. Vaxcyte
Performance |
| Timeline |
| Bio Techne Corp |
| Vaxcyte |
Bio Techne and Vaxcyte Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Bio Techne and Vaxcyte
The main advantage of trading using opposite Bio Techne and Vaxcyte positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bio Techne position performs unexpectedly, Vaxcyte can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxcyte will offset losses from the drop in Vaxcyte's long position.| Bio Techne vs. Biomarin Pharmaceutical | Bio Techne vs. Vaxcyte | Bio Techne vs. Liquidia Technologies | Bio Techne vs. Legend Biotech Corp |
| Vaxcyte vs. Larimar Therapeutics | Vaxcyte vs. Syndax Pharmaceuticals | Vaxcyte vs. Merus BV | Vaxcyte vs. Sutro Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Stocks Directory Find actively traded stocks across global markets | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |